{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T22:28:40Z","timestamp":1665527320011},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1006\/gyno.2000.6088","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"53-57","source":"Crossref","is-referenced-by-count":25,"title":["Concomitant Radiotherapy and Paclitaxel for High-Risk Endometrial Cancer: First Feasibility Study"],"prefix":"10.1006","volume":"81","author":[{"given":"Luigi","family":"Frigerio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Mangili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Garavaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Beatrice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.6088_RF1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00001622-199909000-00012","article-title":"Endometrial cancer","volume":"1","author":"Bristow","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"10.1006\/gyno.2000.6088_RF2","first-page":"28","article-title":"Endometrial cancer: Risk factors and diagnosis","volume":"92","author":"Clark","year":"1996","journal-title":"W V Med J"},{"key":"10.1006\/gyno.2000.6088_RF3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/gyno.2000.5843","article-title":"Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival","volume":"78","author":"Bristow","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0090-8258(89)90027-9","volume":"35","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0360-3016(92)90786-H","article-title":"Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new Figo surgical staging system","volume":"22","author":"Grisby","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2000.6088_RF6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical\u2013pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/0002-9378(93)90370-X","article-title":"Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients","volume":"168","author":"Podratz","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6088_RF8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9378(94)70222-5","article-title":"Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical\u2013pathologic parameters","volume":"170","author":"Susini","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6088_RF9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00003081-199609000-00017","article-title":"Endometrial neoplasia: prognostic significance of ploidy status","volume":"39","author":"Evans","year":"1996","journal-title":"Clinical Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6088_RF10","first-page":"419","article-title":"Postoperative exteranl irradiation and prognostic parameters in stage I endometrial carcinoma","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6088_RF11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0090-8258(87)90291-5","article-title":"Prognostic factors and sites of failure in FIGO I grade 3 endometrial carcinoma","volume":"27","author":"Chambers","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(92)90134-5","article-title":"Detection and patterns of treatment failure in 300 consecutive cases of \u201cearly\u201d endometrial cancer after primary surgery","volume":"47","author":"Podczaski","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF13","first-page":"1087","article-title":"Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system","volume":"17","author":"Curran","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2000.6088_RF14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1996.0022","article-title":"Endometrial carcinoma\u2014relative effectiveness of adjuvant irradiation vs therapy reserved for relapse","volume":"60","author":"Ackerman","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1996.0227","article-title":"A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"62","author":"Ball","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1008221310453","article-title":"Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma","volume":"8","author":"Lissoni","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1006\/gyno.2000.6088_RF17","doi-asserted-by":"crossref","unstructured":"Weiss, M, F, Connell, P, P, Waggoner, S, Rotmensch, J, Mundt, A, J. External pelvic radiation therapy in stage IC endometrial carcinoma. Obstet Gynecol93:599\u2013602, 1999","DOI":"10.1016\/S0029-7844(98)00479-7"},{"key":"10.1006\/gyno.2000.6088_RF18","first-page":"135","article-title":"A phase III randomized study of surgery versus surgery plus adjuntive dadiation therapy in intermediate risk endometrial cancer. (GOG No.99)","volume":"68","author":"Roberts","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/gyno.1994.1245","article-title":"Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high risk endometrial carcinoma","volume":"55","author":"Burke","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","article-title":"Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high risk endometrial carcinoma stage I and occult stage II. A Gynecologic Oncology Group Study","volume":"36","author":"Morrow","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF21","first-page":"85","article-title":"Risk groups and adjuvant therapy in surgical staged endometrial cancer patients. A randomized multicenter study comparing chemotherapy with radiation therapy","volume":"9","author":"Maggi","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1006\/gyno.2000.6088_RF22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/gyno.1999.5407","article-title":"Persistent chemosensitivity to platinum and\/or paclitaxel in metastatic endometrial cancer","volume":"73","author":"Markman","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.6088_RF23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0169(200003)45:3<223::AID-CM5>3.0.CO;2-Q","article-title":"Disruption of microtubules in living cells by tyrphostin AG-1714","volume":"45","author":"Volberg","year":"2000","journal-title":"Cell Motil Cytoskel"},{"key":"10.1006\/gyno.2000.6088_RF24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00001813-199603000-00006","article-title":"Paclitaxel sensitizes multidrug resistant cells to radiation","volume":"7","author":"Mote","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1006\/gyno.2000.6088_RF25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0360-3016(96)00535-4","article-title":"Cytotoxicity and cell-cycle effects of paclitaxel when used as single agent and in combination with ionizing radiation","volume":"37","author":"Gupta","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2000.6088_RF26","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.1994.12.12.2682","article-title":"Phase I trial of outpatient weekly paclitaxel and concurrent radiotherapy for advanced non small cell lung cancer","volume":"12","author":"Choy","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2000.6088_RF27","first-page":"108","article-title":"paclitaxel and simultaneous radiation in the treatment of non small cell lung cancer","volume":"23","author":"Wolf","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2000.6088_RF28","first-page":"85","article-title":"Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A\/B) non-small cell lung cancer (NSCLC): a preliminary report","volume":"83","author":"Ratanatharathorn","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"10.1006\/gyno.2000.6088_RF29","first-page":"53","article-title":"Paclitaxel and concurrent radiation therapy for locally advanced carcinoma of the pancreas, stomach and gastroesophageal junction","volume":"9","author":"Safran","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1006\/gyno.2000.6088_RF30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2741\/A222","article-title":"Weekly paclitaxel as a radiation sensitizer for locally advanced pancreatic cancers: the Brown University Oncology Group experience","volume":"2","author":"Sikov","year":"1997","journal-title":"Front Biosci"},{"key":"10.1006\/gyno.2000.6088_RF31","first-page":"179","article-title":"One hour paclitaxel infusion: review of safety and efficacy","volume":"5","author":"Greco","year":"1999","journal-title":"Cancer J Sci Am"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800960888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800960888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:27:07Z","timestamp":1557314827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825800960888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0090825800960888"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.6088","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}